OMI Quote, Financials, Valuation and Earnings

Butterfly Network, Inc. has a net margin of -0.8% compared to Owens & Minor, Inc.'s net margin of -158.09%. Owens & Minor, Inc.'s return on equity of -157.86% beat Butterfly Network, Inc.'s return on equity of -38.89%.

Owens & Minor, Inc. has a consensus price target of $5.70, signalling upside risk potential of 110.33%. On the other hand Butterfly Network, Inc. has an analysts' consensus of $3.92 which suggests that it could fall by -0.84%. Given that Owens & Minor, Inc. has higher upside potential than Butterfly Network, Inc., analysts believe Owens & Minor, Inc. is more attractive than Butterfly Network, Inc..

Owens & Minor, Inc. has a beta of 1.367, which suggesting that the stock is 36.728% more volatile than S&P 500. In comparison Butterfly Network, Inc. has a beta of 2.341, suggesting its more volatile than the S&P 500 by 134.054%.

Owens & Minor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Butterfly Network, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owens & Minor, Inc. pays -- of its earnings as a dividend. Butterfly Network, Inc. pays out -- of its earnings as a dividend.

Owens & Minor, Inc. quarterly revenues are $697.3M, which are larger than Butterfly Network, Inc. quarterly revenues of $21.5M. Owens & Minor, Inc.'s net income of -$5.6M is higher than Butterfly Network, Inc.'s net income of -$34M. Notably, Owens & Minor, Inc.'s price-to-earnings ratio is -- while Butterfly Network, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owens & Minor, Inc. is 0.03x versus 10.58x for Butterfly Network, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Intelligent Bio Solutions, Inc. has a net margin of -0.8% compared to Owens & Minor, Inc.'s net margin of -269.38%. Owens & Minor, Inc.'s return on equity of -157.86% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.

Owens & Minor, Inc. has a consensus price target of $5.70, signalling upside risk potential of 110.33%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 2309.64%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Owens & Minor, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Owens & Minor, Inc..

Owens & Minor, Inc. has a beta of 1.367, which suggesting that the stock is 36.728% more volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Owens & Minor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owens & Minor, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.

Owens & Minor, Inc. quarterly revenues are $697.3M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Owens & Minor, Inc.'s net income of -$5.6M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Owens & Minor, Inc.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owens & Minor, Inc. is 0.03x versus 9.90x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools, Inc. has a net margin of -0.8% compared to Owens & Minor, Inc.'s net margin of -162.05%. Owens & Minor, Inc.'s return on equity of -157.86% beat Standard BioTools, Inc.'s return on equity of -24.44%.

Owens & Minor, Inc. has a consensus price target of $5.70, signalling upside risk potential of 110.33%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 5.44%. Given that Owens & Minor, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Owens & Minor, Inc. is more attractive than Standard BioTools, Inc..

Owens & Minor, Inc. has a beta of 1.367, which suggesting that the stock is 36.728% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.

Owens & Minor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owens & Minor, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

Owens & Minor, Inc. quarterly revenues are $697.3M, which are larger than Standard BioTools, Inc. quarterly revenues of $19.6M. Owens & Minor, Inc.'s net income of -$5.6M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Owens & Minor, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owens & Minor, Inc. is 0.03x versus 4.32x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR, Inc. has a net margin of -0.8% compared to Owens & Minor, Inc.'s net margin of -25.94%. Owens & Minor, Inc.'s return on equity of -157.86% beat LENSAR, Inc.'s return on equity of -1013.45%.

Owens & Minor, Inc. has a consensus price target of $5.70, signalling upside risk potential of 110.33%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.9%. Given that Owens & Minor, Inc. has higher upside potential than LENSAR, Inc., analysts believe Owens & Minor, Inc. is more attractive than LENSAR, Inc..

Owens & Minor, Inc. has a beta of 1.367, which suggesting that the stock is 36.728% more volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.

Owens & Minor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owens & Minor, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.

Owens & Minor, Inc. quarterly revenues are $697.3M, which are larger than LENSAR, Inc. quarterly revenues of $14.3M. Owens & Minor, Inc.'s net income of -$5.6M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Owens & Minor, Inc.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owens & Minor, Inc. is 0.03x versus 2.41x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.